摘要
目前分化型甲状腺癌(DTC)的治疗方法是以手术为主的个体化方案。由于DTC具有较多惰性癌特性,非手术的药物治疗如促甲状腺激素(TSH)抑制治疗、分子靶向治疗、新辅助化疗、中药治疗等逐渐成为研究热点。文章主要就以上DTC常见药物的治疗进展进行综述,以提高对DTC药物治疗的认识。
The main treatment model for differentiated thyroid cancer is surgery-based individualized treatment. Due to the inert cancer characteristics of DTC,drug therapies such as thyrotropin suppressive therapy,molecular targeted therapy,neoadjuvant chemotherapy and Chinese medicine treatment have become the current research hotspots. Here,we reviewed the progress of clinical medication for DTC to improve the understanding of DTC drug therapy.
作者
叶丽姿
乐岭
YE Li-zi reviewing, YUE Ling checking(Department of Endocrinology, Wuhan General Hospital of Chinese People's Military Army, Wuhan 430070, Hubei, China)
出处
《医学研究生学报》
CAS
北大核心
2018年第5期544-549,共6页
Journal of Medical Postgraduates
基金
湖北省自然科学基金(2017CFB797)
关键词
分化型甲状腺癌
非手术治疗
药物治疗
differentiated thyroid cancer
non-surgical therapy
drug therapy